CIPO Patents = 1

Forward Citations = 90

Loading Chart...

6 inventors (with patents filed for the assignee):

Mark D Erion (5 out of 61 patents)

John A Secrist, Iii (5 out of 39 patents)

John A Montgomery (5 out of 60 patents)

4. Steve E Ealick (5 out of 8 patents)

5. Wayne C Guida (5 out of 6 patents)

6. Shri Niwas (1 out of 5 patents)

7. Steven E Ealick (0 patent)

8. Iii Secrist John A (0 patent)

5 patents: Sort by Forward Citations

1. 5189039 - 7-disubstituted-methyl-4-oxo-3H,5H-pyrrolo[3,2d]pyrimidine and (1993-02-23),

2. 5008270 - 2-amino-7-(heterocyclomethyl)-3H,5H-pyrrolo[3,2-d]pyrimidin-4-ones and (1991-04-16),

3. 5008265 - 2-amino-7-(alicyclomethyl)-3H,5H,-pyrrolo[3,2-d]pyrimidin-4-ones and (1991-04-16),

4. 4985434 - 7-substituted derivatives of (1991-01-15),

5. 4985433 - 2-amino-7-(pyridinylmethyl)-3H,5H-pyrrolo[3,2-d]pyrimidin-4-ones and (1991-01-15),

Founded in 1986, Biocryst, Inc. is a biotechnology company specializing in the development of oral and small molecule drugs for rare and serious diseases. The company has a strong focus on developing innovative therapies for hereditary angioedema and other rare genetic diseases. Biocryst's research and development efforts aim to improve the lives of patients by bringing novel treatments to market. With a commitment to scientific excellence and patient-centered innovation, Biocryst is dedicated to advancing the field of biotechnology and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

5 Patents

#47 in Birmingham, AL

#236 in Alabama

#50,255 in US

Birmingham, AL, United States of America

Biocryst, Inc.